Sarepta: Sarepta indicates it's safe to continue Elevidys dosing in Europe; Epsilogen buys TigaTx
Plus, news about Vickers Venture Partners: Sarepta Therapeutics says safety board clears paused Elevidys trials: An independent data monitoring committee concluded that three studies of the Duchenne ...
Read full article »
Sarepta is a Massachusetts-based biotechnology company that discovers and develops genetic medicines for the treatment of neuromuscular diseases.
Read more